2Balch CM, Soong S, Ross ML, et al. long-term results of amulti-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness mel- anomas(1.0 to4.0mm).intergroup Melanoma Surgical Trial [J]. Ann Srug Oncol, 2000, 7(2):87-97.
3Buhanan D J, SchlaerthJ, KurosakiT, et al. Primary vaginal melanoma:Thirteen-year disease-free survival after wide local excision and review of recent literature[J]. Am J Ob- stetGynecol, 1998,178 (6): 1177-1184.
2Weyandt GH,Eggert AQ,houf M,et al.Anorectal melanoma surgical management guidelines according to tumoklr thickness[J].Br J can- cer,2003,89(11):2 019-2 022.
3I Ulmer A,Metzger S,Fierlbeck G.Successful palliation of stenosing anoreetal melanoma by intratum oral injections with natural inter- feron beta[J].melanoma Res,2002,12(4):395-398.
4Moozar C,Wong CS,Couture J.Anorectal malignant mela- noma treatment with suygery or radiation therapy,or both [J]. CardSurg,2003,46(5):345 -349.
5Schweiger ES,Kwasniak L,Tonkovic-Capin V.A patient with neviod basal cell carcinoma syndrome treated successfully with photody- namic therapy: case report and review of the literature[J].J Drugs Dermatol,2010,Feb,9(2): 167-168.
6Hersey P.Active immunotherapy with riral lysates of mierometastaes following surgical remoral of high mdanoma[J].world surg,1992, 16:251.
7Cox NH,Eedy DJ,Morton CA. Guidelines for management of Bowenxs disease. British Association of Dermatologists [ J ]. Br J Dermatol,1999,141(4):633-641.
